Clinical case of a patient undergoing radium-223 treatment following treatment with abiraterone acetate and enzalutamide

Objective: Over the last decade, significant advances have been made in the development of therapies for patients with metastatic castration-resistant prostate cancer. Abiraterone and enzalutamide were approved as treatments based on data supporting improved overall survival compared to placebo. Rad...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental Oncology
Datum:2018
Hauptverfasser: Jiménez Romero, M.E., Díez Farto, S., Navarro Serrato, J.C., Canelón Castillo, E., Revelo Cadena, I.
Format: Artikel
Sprache:English
Veröffentlicht: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2018
Schlagworte:
Online Zugang:https://nasplib.isofts.kiev.ua/handle/123456789/145592
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Назва журналу:Digital Library of Periodicals of National Academy of Sciences of Ukraine
Zitieren:Clinical case of a patient undergoing radium-223 treatment following treatment with abiraterone acetate and enzalutamide / M.E. Jiménez Romero, S. Díez Farto, J.C. Navarro Serrato, E. Canelón Castillo, I. Revelo Cadena // Experimental Oncology. — 2018 — Т. 40, № 2. — С. 144–148. — Бібліогр.: 13 назв. — англ.

Institution

Digital Library of Periodicals of National Academy of Sciences of Ukraine